These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1098955)

  • 1. Hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine.
    Marubbio AT; Danielson B
    Gastroenterology; 1975 Sep; 69(3):739-43. PubMed ID: 1098955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favourable outcome of hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine, treated by portacaval shunt. Report of a case and review of the literature.
    Eisenhauer T; Hartmann H; Rumpf KW; Helmchen U; Scheler F; Creutzfeldt W
    Digestion; 1984; 30(3):185-90. PubMed ID: 6389237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic vascular disease after kidney transplantation: report of two cases and review of the literature.
    Adler M; Delhaye M; Deprez C; Hardy N; Gelin M; De Pauw L; Vereerstraeten P; Cremer M; Toussaint C
    Nephrol Dial Transplant; 1987; 2(3):183-8. PubMed ID: 3114679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: light microscopy and ultrastructural observations.
    Haboubi NY; Ali HH; Whitwell HL; Ackrill P
    Am J Gastroenterol; 1988 Mar; 83(3):256-61. PubMed ID: 3278593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver disease in renal transplant recipients.
    Sopko J; Anuras S
    Am J Med; 1978 Jan; 64(1):139-46. PubMed ID: 203190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azathioprine-induced hepatic veno-occlusive disease in a renal transplant recipient: histological regression following azathioprine withdrawal.
    Kohli HS; Jain D; Sud K; Jha V; Gupta KL; Sakhuja V; Joshi K
    Nephrol Dial Transplant; 1996 Aug; 11(8):1671-2. PubMed ID: 8856241
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic dysfunction in recipients of renal allografts.
    Berne TV; Chatterjee SN; Craig JR; Payne JE
    Surg Gynecol Obstet; 1975 Aug; 141(2):171-5. PubMed ID: 168654
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatic sinusoidal dilatation with portal hypertension during azathioprine treatment: a cause of chronic liver disease after kidney transplantation.
    Gerlag PG; van Hooff JP
    Transplant Proc; 1987 Oct; 19(5):3699-703. PubMed ID: 3313895
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapy.
    Read AE; Wiesner RH; LaBrecque DR; Tifft JG; Mullen KD; Sheer RL; Petrelli M; Ricanati ES; McCullough AJ
    Ann Intern Med; 1986 May; 104(5):651-5. PubMed ID: 3008617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azathioprine and hepatic venocclusive disease in renal transplant patients.
    Katzka DA; Saul SH; Jorkasky D; Sigal H; Reynolds JC; Soloway RD
    Gastroenterology; 1986 Feb; 90(2):446-54. PubMed ID: 3510146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of severe azathioprine-induced hepatic veno-occlusive disease in a kidney-transplanted patient with transjugular intrahepatic portosystemic shunt.
    Azoulay D; Castaing D; Lemoine A; Samuel D; Majno P; Reynes M; Charpentier B; Bismuth H
    Clin Nephrol; 1998 Aug; 50(2):118-22. PubMed ID: 9725784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide (CP) substituting azathioprine after renal transplantation.
    Andreu J; Caralps A; Brulles A; Lloveras J; Masramon J; Gil-Vernet JM
    Proc Eur Dial Transplant Assoc; 1976; 12():434-40. PubMed ID: 778835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatic veno-occlusive disease associated to the use of azathioprine in a renal transplant recipient].
    Hola K; Brahm J; Alvo M; Cotera A; Passalacqua W; Smok G
    Rev Med Chil; 1996 Dec; 124(12):1489-91. PubMed ID: 9334484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Veno-occlusive disease of the liver].
    Leger L; Dentan T; Lemaigre G
    Presse Med (1893); 1970 Aug; 78(36):1559-60. PubMed ID: 5456286
    [No Abstract]   [Full Text] [Related]  

  • 15. Irreversible liver damage after azathioprine.
    Zarday Z; Veith FJ; Gliedman ML; Soberman R
    JAMA; 1972 Nov; 222(6):690-1. PubMed ID: 4562099
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic veno-occlusive disease due to DTIC.
    Asbury RF; Rosenthal SN; Descalzi ME; Ratcliffe RL; Arseneau JC
    Cancer; 1980 May; 45(10):2670-4. PubMed ID: 7379000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver disease in kidney transplant patients receiving azathioprine.
    Ireland P; Rashid A; von Lichtenberg F; Cavallo T; Merrill JP
    Arch Intern Med; 1973 Jul; 132(1):29-37. PubMed ID: 4577390
    [No Abstract]   [Full Text] [Related]  

  • 18. Veno-occlusive hepatic disease of the liver in renal transplantation: is azathioprine the cause?
    Liaño F; Moreno A; Matesanz R; Teruel JL; Redondo C; García-Martín F; Orte L; Ortuño J
    Nephron; 1989; 51(4):509-16. PubMed ID: 2662036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructure of peliosis hepatis in a percutaneous biopsy.
    Ross RC; Kovacs K; Horvath E
    Pathol Eur; 1972; 7(3):273-82. PubMed ID: 4571538
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonicteric liver damage with a gamma-glutamyl transpeptidase level of 5,609 units/l in a renal-transplant recipient receiving azathioprine.
    Watanabe A; Obata T; Nagashima H; Sakagami K; Orita K
    Acta Med Okayama; 1984 Dec; 38(6):533-9. PubMed ID: 6151783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.